Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy

Shane Y. Morita, Helina Somervell, Christopher B. Umbricht, Alan P B Dackiw, Martha A. Zeiger

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Previous investigators have reported the incidence of thyroid nodules in patients with primary hyperparathyroidism; others have noted the incidence of primary hyperparathyroidism in patients who underwent thyroidectomy. It is well known that both of these entities coexist. In this article, we present a single-center experience with the incidence of concomitant thyroid nodular disease and primary hyperparathyroidism in patients who underwent parathyroidectomy or thyroidectomy. Methods: From May 2006 to December 2007, 526 patients underwent thyroidectomy, parathyroidectomy, or both. Operations were performed by surgeons in the Johns Hopkins Endocrine Surgery Section after screening preoperatively for concomitant thyroid nodular disease or primary hyperparathyroidism. Results: Among the 200 patients who underwent a parathyroidectomy, 102 (51.0%) were found to have thyroid nodular disease. Six percent of these 200 patients also had a thyroid malignancy. Of the 326 patients who were primarily seen for thyroid disease, the incidence of primary hyperparathyroidism was 3.1%. Conclusion: By implementing a comprehensive approach to patients who present with thyroid disease or primary hyperparathyroidism, concomitant pathology may be elucidated preoperatively. This approach will facilitate the detection of otherwise unsuspected thyroid cancer and hyperparathyroidism as well as prevent unnecessary reoperative surgery.

Original languageEnglish (US)
Pages (from-to)862-867
Number of pages6
JournalSurgery
Volume144
Issue number6
DOIs
StatePublished - Dec 2008

Fingerprint

Parathyroidectomy
Thyroid Nodule
Primary Hyperparathyroidism
Thyroidectomy
Thyroid Diseases
Incidence
Unnecessary Procedures
Hyperparathyroidism
Thyroid Neoplasms
Thyroid Gland
Research Personnel
Pathology

ASJC Scopus subject areas

  • Surgery

Cite this

Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. / Morita, Shane Y.; Somervell, Helina; Umbricht, Christopher B.; Dackiw, Alan P B; Zeiger, Martha A.

In: Surgery, Vol. 144, No. 6, 12.2008, p. 862-867.

Research output: Contribution to journalArticle

Morita, Shane Y. ; Somervell, Helina ; Umbricht, Christopher B. ; Dackiw, Alan P B ; Zeiger, Martha A. / Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. In: Surgery. 2008 ; Vol. 144, No. 6. pp. 862-867.
@article{3cc6722923ba4323a2700b88ceca534e,
title = "Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy",
abstract = "Background: Previous investigators have reported the incidence of thyroid nodules in patients with primary hyperparathyroidism; others have noted the incidence of primary hyperparathyroidism in patients who underwent thyroidectomy. It is well known that both of these entities coexist. In this article, we present a single-center experience with the incidence of concomitant thyroid nodular disease and primary hyperparathyroidism in patients who underwent parathyroidectomy or thyroidectomy. Methods: From May 2006 to December 2007, 526 patients underwent thyroidectomy, parathyroidectomy, or both. Operations were performed by surgeons in the Johns Hopkins Endocrine Surgery Section after screening preoperatively for concomitant thyroid nodular disease or primary hyperparathyroidism. Results: Among the 200 patients who underwent a parathyroidectomy, 102 (51.0{\%}) were found to have thyroid nodular disease. Six percent of these 200 patients also had a thyroid malignancy. Of the 326 patients who were primarily seen for thyroid disease, the incidence of primary hyperparathyroidism was 3.1{\%}. Conclusion: By implementing a comprehensive approach to patients who present with thyroid disease or primary hyperparathyroidism, concomitant pathology may be elucidated preoperatively. This approach will facilitate the detection of otherwise unsuspected thyroid cancer and hyperparathyroidism as well as prevent unnecessary reoperative surgery.",
author = "Morita, {Shane Y.} and Helina Somervell and Umbricht, {Christopher B.} and Dackiw, {Alan P B} and Zeiger, {Martha A.}",
year = "2008",
month = "12",
doi = "10.1016/j.surg.2008.07.029",
language = "English (US)",
volume = "144",
pages = "862--867",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy

AU - Morita, Shane Y.

AU - Somervell, Helina

AU - Umbricht, Christopher B.

AU - Dackiw, Alan P B

AU - Zeiger, Martha A.

PY - 2008/12

Y1 - 2008/12

N2 - Background: Previous investigators have reported the incidence of thyroid nodules in patients with primary hyperparathyroidism; others have noted the incidence of primary hyperparathyroidism in patients who underwent thyroidectomy. It is well known that both of these entities coexist. In this article, we present a single-center experience with the incidence of concomitant thyroid nodular disease and primary hyperparathyroidism in patients who underwent parathyroidectomy or thyroidectomy. Methods: From May 2006 to December 2007, 526 patients underwent thyroidectomy, parathyroidectomy, or both. Operations were performed by surgeons in the Johns Hopkins Endocrine Surgery Section after screening preoperatively for concomitant thyroid nodular disease or primary hyperparathyroidism. Results: Among the 200 patients who underwent a parathyroidectomy, 102 (51.0%) were found to have thyroid nodular disease. Six percent of these 200 patients also had a thyroid malignancy. Of the 326 patients who were primarily seen for thyroid disease, the incidence of primary hyperparathyroidism was 3.1%. Conclusion: By implementing a comprehensive approach to patients who present with thyroid disease or primary hyperparathyroidism, concomitant pathology may be elucidated preoperatively. This approach will facilitate the detection of otherwise unsuspected thyroid cancer and hyperparathyroidism as well as prevent unnecessary reoperative surgery.

AB - Background: Previous investigators have reported the incidence of thyroid nodules in patients with primary hyperparathyroidism; others have noted the incidence of primary hyperparathyroidism in patients who underwent thyroidectomy. It is well known that both of these entities coexist. In this article, we present a single-center experience with the incidence of concomitant thyroid nodular disease and primary hyperparathyroidism in patients who underwent parathyroidectomy or thyroidectomy. Methods: From May 2006 to December 2007, 526 patients underwent thyroidectomy, parathyroidectomy, or both. Operations were performed by surgeons in the Johns Hopkins Endocrine Surgery Section after screening preoperatively for concomitant thyroid nodular disease or primary hyperparathyroidism. Results: Among the 200 patients who underwent a parathyroidectomy, 102 (51.0%) were found to have thyroid nodular disease. Six percent of these 200 patients also had a thyroid malignancy. Of the 326 patients who were primarily seen for thyroid disease, the incidence of primary hyperparathyroidism was 3.1%. Conclusion: By implementing a comprehensive approach to patients who present with thyroid disease or primary hyperparathyroidism, concomitant pathology may be elucidated preoperatively. This approach will facilitate the detection of otherwise unsuspected thyroid cancer and hyperparathyroidism as well as prevent unnecessary reoperative surgery.

UR - http://www.scopus.com/inward/record.url?scp=56449086995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449086995&partnerID=8YFLogxK

U2 - 10.1016/j.surg.2008.07.029

DO - 10.1016/j.surg.2008.07.029

M3 - Article

C2 - 19040989

AN - SCOPUS:56449086995

VL - 144

SP - 862

EP - 867

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -